TNF and neoplasm: Phase I trials of DMXAA show evidence of decreased tumour blood flow (Rustin et al, 1998; Jameson et al, 2000) and increased plasma 5HIAA (Kestell et al, 2001), but only a small increase in plasma nitrate and no increase in plasma TNF (Jameson et al, 2000).